Catalyst Wire Dossier Catalyst Wire Dossier

QR052107B Tablets

QR052107B · Wuhan Createrna Science and Technology Co., Ltd
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for QR052107B Tablets, covering 2025-04-10 to 2025-04-10. Get the full timeline:

Most recent: Clinical Trial Update: QR052107B Tablets in Patients With Subacute Cough of Phase Ⅱ Study [Phase 2]

See pricing